Vortex Pharma Solution ApS
Private limited companyCVR 43009672BagsværdActive
Vortex Pharma Solution ApS is a private limited company, based in Bagsværd, active in other technical consultancy, founded in 2022. The company went from a profit in 2024 to a loss of DKK 34,561 in 2025. Equity fell to DKK 111k in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 58% (2024 → 2025), to DKK 256k.
- Net profit went from a profit of DKK 303k to a loss of DKK 34,561 (2024 → 2025).
- Equity fell 24% (2024 → 2025), to DKK 111k.
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2022–2025 · amounts in DKK thousandEquity and net profit
| 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | – |
| Gross profit | 319 | −59 | 613 | 256 | −58.3% |
| Operating profit (EBIT) | 227 | −293 | 314 | −29 | −109.1% |
| Profit before tax | 225 | −295 | 312 | −35 | −111.1% |
| Net profit | 173 | −295 | 303 | −35 | −111.4% |
| Total assets | 455 | 280 | 515 | 410 | −20.3% |
| Equity | 213 | −157 | 146 | 111 | −23.7% |
| Liabilities | – | – | – | 299 | – |
| Cash and cash equivalents | 288 | 86 | 515 | 406 | −21.1% |
| Average number of employees | 0 | 2 | 2 | 2 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
4 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 15/04/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 20/06/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 03/06/2024 | The company | PDFXBRL |
| 2022 | 26/01/2022 – 31/12/2022 | 13/06/2023 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
440 companies in the databaseComparison with the other companies in other technical consultancy based on the latest financial year.
Industry median: gross profit DKK 1.9m, net profit DKK 210k, equity DKK 874k, 2 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 58,505of 69,742 Better than 16% | No. 54,247of 69,964 Better than 22% |
| Same industry and fewer than 20 employees396 companies in the comparison | No. 331of 396 Better than 16% | No. 324of 396 Better than 18% |
| Companies that are founded within the last five years16,675 companies in the comparison | No. 13,488of 16,627 Better than 19% | No. 9,988of 16,674 Better than 40% |
| All companies of type ApS66,508 companies in the comparison | No. 56,280of 66,379 Better than 15% | No. 50,405of 66,505 Better than 24% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Other technical consultancy- Vortex Pharma Solution ApSDKK 256k
- Nordomatic A/SDKK 172.8m
- NRGi Rådgivning A/SDKK 113.6m
- Vortex Pharma Solution ApS−DKK 34,561
- Nordomatic A/SDKK 37.7m
- NRGi Rådgivning A/S−DKK 26.3m
- Vortex Pharma Solution ApSDKK 111k
- Nordomatic A/SDKK 102.5m
- NRGi Rådgivning A/SDKK 28.6m
- Vortex Pharma Solution ApS2
- Nordomatic A/S173
- NRGi Rådgivning A/S183
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Vortex Holdings ApS100%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Flavia Christina Ladwig Robles | CEO | 26/01/2022 |
- Founders
- Vortex Holdings ApS
Signing rule: Selskabet tegnes af direktøren
Address and production units
1 active production unitsHjortevænget 32
2880 Bagsværd
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Vortex Pharma Solution ApS | Hjortevænget 32, 2880 Bagsværd | 3 | 1027940443 |
Purpose
Selskabets formål er at drive konsulentvirksomhed inden for klinisk udvikling og dermed beslægtet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
7 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20251 changeaccounts 1
- AccountsAnnual report for 2024 published
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20223 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as Vortex Pharma Solution ApS
- ManagementFlavia Christina Ladwig Robles appointed ceo
- OwnershipVortex Holdings ApS registered as owner (100%)
Related companies
Same industry in Gladsaxe
- Human House A/S101 employees
- 21st.BIO A/S44 employees
- Visibuilt ApS18 employees
- Trap Rose & Ekblad, Rådgivende Ingeniører og Biologer ApS8 employees
- E-consult ApS6 employees
- FZ Green World ApS2 employees
Largest in the industry
- Nordomatic A/SDKK 172.8m
- NRGi Rådgivning A/SDKK 113.6m
- Viegand Maagøe A/SDKK 90.1m
- Dall Energy ApSDKK 86.9m
- Ce-tec A/SDKK 76m
- New Power Partners ApSDKK 66m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.